Gbio Bt(Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 1.00 K
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -103.42%
- Ebitda 61.02%
- Net Worth -4.78%
- Total Assets -4.60%
About Gbio Bt(Opc)
Gbio Bt Private Limited (Opc) (GBPLO) is a Company incorporated in India on 17 July 2018 (Six years and seven months 10 days old ). Its registered office is in Gautam Buddha Nagar, Uttar Pradesh, India.
The Corporate was formerly known as Gbio Bt Private Limited. The Company is engaged in the Plastics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 1.00 K , as per Ministry of Corporate Affairs (MCA) records.
Rohit Aggarwal serves as a director at the Company.
Company Details
- Location
Gautam Buddha Nagar, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U25208UP2018OPC106303
- Company No.
106303
- Incorporation Date
17 Jul 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Gbio Bt(Opc)?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Aggarwal  | Director | 09-Dec-2019 | Current |
Financial Performance of Gbio Bt(Opc).
Gbio Bt Private Limited (Opc), for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 103.42% decrease in profit. The company's net worth dipped by a decrease of 4.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gbio Bt(Opc)?
Unlock access to Gbio Bt(Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Nandini Buildhome Consortium Private LimitedRohit Aggarwal is a mutual person
Metro Suites Homes LlpRohit Aggarwal is a mutual person
- S R B Consortium (Realcon) Private Limited
Rohit Aggarwal is a mutual person
- M-Suites Infra Private Limited
Rohit Aggarwal is a mutual person
- Metro Suites Developers Private Limited
Rohit Aggarwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gbio Bt(Opc)?
Unlock and access historical data on people associated with Gbio Bt(Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gbio Bt(Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gbio Bt(Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
